Education
About Us
Working with TipRanks
Follow Us
Photocure ASA (PHCUF)
OTHER OTC:PHCUF
PHCUF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.85 - $6.81
Previous CloseN/A
Volume400.00
Average Volume (3M)0.00
Market Cap
$156.81M
Enterprise Value$1.21B
Total Cash (Recent Filing)$259.54M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)2127.6
Beta0.30
Next Earnings
Oct 29, 2025EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding27,120,820
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap7.74
Enterprise Value/Revenue2.28
Enterprise Value/Gross Profit2.46
Enterprise Value/Ebitda19.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Photocure ASA News
PHCUF FAQ
What was Photocure ASA’s price range in the past 12 months?
Photocure ASA lowest stock price was $3.85 and its highest was $6.81 in the past 12 months.
What is Photocure ASA’s market cap?
Photocure ASA’s market cap is $156.81M.
When is Photocure ASA’s upcoming earnings report date?
Photocure ASA’s upcoming earnings report date is Oct 29, 2025 which is in 30 days.
How were Photocure ASA’s earnings last quarter?
Photocure ASA released its earnings results on Jul 30, 2025. The company reported $0.018 earnings per share for the quarter, beating the consensus estimate of -$0.003 by $0.021.
Is Photocure ASA overvalued?
According to Wall Street analysts Photocure ASA’s price is currently Overvalued.
Does Photocure ASA pay dividends?
Photocure ASA does not currently pay dividends.
What is Photocure ASA’s EPS estimate?
Photocure ASA’s EPS estimate is <0.01.
How many shares outstanding does Photocure ASA have?
Photocure ASA has 27,120,820 shares outstanding.
What happened to Photocure ASA’s price movement after its last earnings report?
Photocure ASA reported an EPS of $0.018 in its last earnings report, beating expectations of -$0.003. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Photocure ASA?
Currently, no hedge funds are holding shares in PHCUF
Company Description
Photocure ASA
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.
PHCUF Company Deck
PHCUF Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call for Photocure presented a positive outlook with strong revenue growth, particularly in Europe, and successful strategic initiatives like the ForTec mobile strategy. Despite some challenges such as foreign exchange impacts and delays in the Chinese market launch, the company maintained positive EBITDA and increased its cash reserves.View all PHCUF earnings summariesTechnical Analysis
Catalyst Pharma
―
Eagle Pharmaceuticals
―
Omeros
―
Tonix Pharma
―
Oncolytics Biotech
―
Pfizer
―
Ownership Overview
―
Insiders
0.05% Mutual Funds
― Other Institutional Investors
99.73% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---